Future Outlook In obesity care, novel therapies could minimize side effects
Generally yes, but exercise caution with stacking multiple blood-sugar-lowering compounds
Conclusion Despite an excellent design and a pristine execution, EVOKE and EVOKE+ offer a clear, albeit sobering, lesson: promising real-world correlations and mechanistic rationale do not automatically translate into disease-modifying effects in symptomatic Alzheimers disease
While the medication has transformed weight loss for millions, the rules for breastfeeding mothers are more complex than a simple yes or no. As of early 2026, the official stance from the FDA remains cautious
However, their side effects on the cardiovascular, psychological, and gastrointestinal systems have prompted the search for safer treatments